Pediatric endocrinologist Dr. Casey Berman says GLP-1s may help children reduce their risk of developing serious health ...

Patients with idiopathic intracranial hypertension who use a GLP-1 receptor agonist are less likely to experience symptoms, require medications, or undergo surgery.

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Low rates of retained gastric contents were seen in endoscopy patients on GLP-1 receptor agonists ( RAs), a retrospective ...

A new report from The Center for Medicine in the Public Interest (CMPI) warns that regulators are failing to stop the illegal ...

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor agonists offer neuroprotective and cerebrovascular benefits beyond what can ...

This new class of GLP-1 weight loss drugs may feel like a miracle, but it still takes effort from you for these meds to work safely and effectively.

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.

National Weight Loss Doctor Scott Masey joined Bloom Health Club to explain what GLP-1 drugs really do, and what most people aren’t being told. “These meds don’t just help with ...

Medication paired with behavioral change support gives employers the opportunity to provide a more well-rounded approach to ...

Natalie Muth, MD, MPH, RDN, is an adjunct associate professor at UCLA Fielding School of Public Health; co-founder of Namio ...

Weight loss medications can reduce the efficacy of oral contraceptives. What to know before taking drugs like Ozempic, Mounjaro ...